确诊为中度及重度哮喘前血清中IL-5,IL-6,IL-8,IL-13和IL-17A水平的变化

2019/07/11

   摘要
   背景:支气管哮喘(BA)是一种以持续性气道炎症为特征的复杂疾病。呼出气一氧化氮(FeNO)和外周血嗜酸性粒细胞计数(b-Eos)是2型支气管哮喘的生物学标志物。
   目的:分析中度及重度哮喘患者在通过外周血嗜酸粒细胞及FeNO确诊前血清中的白介素及总免疫球蛋白E。
   方法:在30名健康对照(HC)组和80名成人哮喘患者中测定血清IL-5,IL-6,IL-8,IL-13和IL-17A(ELISA)水平。 BA患者分为4组,第1组:低FeNO /低b-Eos(n = 23; 28.8%);第2组:低FeNO /高b-Eos(n = 17; 21.3%);第3组:高FeNO /低b-Eos(n = 15; 18.8%);第4组:高FeNO /高b-Eos(n = 25; 31.3%)。
   结果:与HC相比,BA患者的所有白细胞介素及总IgE都显着升高。 IL-5水平在第2组中最高(p <0.05)。与HC相比,第2,3和4组的IL-6,IL-13和IL-17A水平升高(p <0.05)。IL-8水平升高与当时吸烟状态相关。在频繁发作的2型哮喘组中发现IL-17A水平最高,并且大多数是难控制哮喘和重症哮喘。根据人口学、临床表现、功能指标、免疫学特点及炎症特点为基础,发现每组独一无二的特点。
   结论:FeNO和b-Eos可用于确定频繁发作的重症2型哮喘亚组。 IL-5,IL-6,IL-13和IL-17A参与中度及重度哮喘中持续性的2型免疫反应。我们已经在真实临床实践中确定了难治性、重度2型/高 IL-17A水平型支气管哮喘特征。

 
(中日友好医院呼吸与危重症医学科 张鑫 摘译 林江涛 审校)
(Respir Med. 2019 Jun 26;154:144-154)
 
 
 
Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined 
groups of adult patients with moderate and severe bronchial asthma.
 
Dimitrova D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, Velikova T.
 
Abstract
BACKGROUND: Bronchial asthma (BA) is a complex disease characterised by persistent inflammation. Exhaled nitric oxide (FeNO) and blood eosinophil count (b-Eos) are biomarkers for type 2 endotype of BA.
OBJECTIVE: To analyse a panel of serum interleukins and total IgE in predefined by FeNO and b-Eos groups of moderate and severe BA patients.
METHODS: Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A (ELISA) were measured in 30 healthy controls (HC) and 80 adult BA patients. BA patients were split into 4 groups. Group 1:Low FeNO/Low b-Eos (n = 23; 28.8%); Group 2:Low FeNO/High b-Eos (n = 17; 21.3%); Group 3:High FeNO/Low b-Eos (n = 15; 18.8%); Group 4:High FeNO/High b-Eos (n = 25; 31.3%).
RESULTS:All interleukins and total IgE were significantly higher in patients with BA as compared with HC. IL-5 levels were highest in Group 2 (p < 0.05). IL-6, IL-13 and IL-17A levels were elevated in Groups 2, 3 and 4 as compared with HC (p < 0.05). Higher IL-8 levelswere associated with a pattern of current smokers. Highest IL-17A levels were found in type 2 high groups with frequent exacerbations, mostly uncontrolled and severe BA. We have found a distinct pattern for each group based on demographic, clinical, functional, immunological and inflammatory characteristics.
CONCLUSION:FeNO and b-Eos are useful in the identification of severe type 2 BA subgroups with frequent exacerbations. IL-5, IL-6, IL-13 and IL-17A are involved in the persistent type 2 immune response in moderate and severe BA. We have identified a pattern of refractory, severe type 2/IL-17A high BA in the real clinical practice.




上一篇: 儿童期和成人期哮喘的遗传结构区别
下一篇: 短期暴露于周围空气污染和哮喘死亡率的影响

用户登录